Clopidogrel and aspirin are the most popular antiplatelet agents for anticoagulation management after coronary artery bypass grafting ( CABG ) in clinical practice , but there is neither a standard antiplatelet therapy for patients undergoing CABG , nor an exact conclusion about its effects on graft patency until now .
